SCHEMBL25415556

SCHEMBL25415556

COC(=O)c1cccc2nc(-c3cc(OC)cc(OC)c3)c(N)n12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 2/20 0.42
▸ CASP1 P29466 1/20 0.42
▸ CASP7 P55210 1/20 0.42
▸ ADORA2A P29274 3/20 0.39
▸ ADORA1 P30542 3/20 0.39
▸ ADORA2B P29275 2/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ MAPT P10636 3/20 0.38
▸ LMNA P02545 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ RIPK2 O43353 1/20 0.38
▸ ADORA3 P0DMS8 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ DAPK3 O43293 1/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ PRKD3 O94806 1/20 0.36
▸ MAP4K4 O95819 1/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ CSF1R P07333 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25417063 0.74 AKT1 (0.46) HSD17B10CASP1CASP7ADORA2AADORA1
SCHEMBL25417762 0.74 TRIM33 (0.48) MAPTF2
SCHEMBL25415154 0.70 NPC1 (0.53) HSD17B10ADORA2AADORA1ADORA2BALDH1A1
SCHEMBL25417713 0.69 ADORA2A (0.44) HSD17B10ADORA2AADORA1ADORA2BALDH1A1
SCHEMBL3430279 0.65 EGLN2 (0.42) —
SCHEMBL3302106 0.65 JAK1 (0.52) HSD17B10ALDH1A1KDM4EMAPTDAPK3
SCHEMBL7863436 0.64 MAPK1 (0.49) HSD17B10ALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL2508253 0.64 MAPK1 (0.37) HSD17B10ALDH1A1KDM4EMAPTSMN1; SMN2
SCHEMBL25416724 0.64 AKT1 (0.51) HSD17B10ALDH1A1KDM4EMAPTSMN1; SMN2
SCHEMBL6520703 0.64 ALDH1A1 (0.41) ALDH1A1KDM4ELMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260071117-A1 FUNABLE FLUORESCENT COMPOUNDS AND USES THEREOF UNIV ARIZONA (US) 2026-03-12 — — US disclosed
WO-2023081261-A1 TUNABLE FLUORESCENT COMPOUNDS AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2023-05-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071117-A1 FUNABLE FLUORESCENT COMPOUNDS AND USES THEREOF H1-3, NISCH, H1-2 HSD17B10 4457/4885CASP1 220/4885CASP7 134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback